Aberdeen Group plc → uniQure N.V. QURE

Stake: — Shares: — Class: Ordinary Shares, par value(euro)0.05 per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 20/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Moderate short days-to-cover (3.8 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

2 transactions

0 buys · 1 sales · 1 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 3.84

8,726,589 shares short · +0.1% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $585K

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-06-17	Kaye Jack	director	Option exercise	5,295	$31.71	$168K
2026-06-17	Kaye Jack	director	Sale	5,295	$42.57	$225K

Other 13D/G Filings on uniQure N.V.

Filed	Form	Filer	Stake	Shares
2019-04-03	SC	Coller International Partners V A LP	—	—	view →
2018-05-09	SC	Coller International Partners V A LP	—	—	view →

Other Filings by Aberdeen Group plc

Filed	Form	Issuer	Stake	Shares
2026-07-29	SCHEDULE 13G	ProQR Therapeutics NV	—	—	view →
2026-07-27	SCHEDULE 13G	Eloxx Pharmaceuticals Inc	—	—	view →
2026-07-20	SCHEDULE 13G/A	CODEXIS, INC.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →